Yarrow Bioscience (YARW) Cash & Equivalents (2016 - 2026)
Yarrow Bioscience (YARW) posted Cash & Equivalents of $22.93 million for Q2 2026, up 4.0% from $22.05 million a year earlier but down 6.9% from the prior quarter.
Powered by 
Analysis
Yarrow Bioscience (YARW) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Yarrow Bioscience's Cash & Equivalents came in at $24.03 million, up 20.6% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- In prior years, Yarrow Bioscience's Cash & Equivalents was $19.93 million in FY2024 (-34.9%), $30.62 million in FY2023 (-0.9%), $30.91 million in FY2022 (-26.8%) and $42.25 million in FY2021 (-26.6%).
- Quarterly Cash & Equivalents has run from a low of $15.45 million in Q3 2023 to a high of $52.31 million in Q3 2021 over five years.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 0.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2025, with growth of 48.0%; the weakest was Q2 2022, with a decline of 58.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Yarrow Bioscience | 19.11 Mn | -97.40 Mn | - | 22.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.93 Mn |
| Mar 31, 2026 | 24.63 Mn |
| Dec 31, 2025 | 24.03 Mn |
| Jun 30, 2025 | 22.05 Mn |
| Mar 31, 2025 | 28.21 Mn |
| Dec 31, 2024 | 19.93 Mn |
| Sep 30, 2024 | 16.27 Mn |
| Jun 30, 2024 | 29.61 Mn |
| Mar 31, 2024 | 19.07 Mn |
| Dec 31, 2023 | 30.62 Mn |
| Sep 30, 2023 | 15.45 Mn |
| Jun 30, 2023 | 20.63 Mn |
| Mar 31, 2023 | 30.21 Mn |
| Dec 31, 2022 | 30.91 Mn |
| Sep 30, 2022 | 35.51 Mn |
| Jun 30, 2022 | 42.81 Mn |
| Mar 31, 2022 | 50.50 Mn |
| Dec 31, 2021 | 42.25 Mn |
| Sep 30, 2021 | 52.31 Mn |
| Jun 30, 2021 | 103.41 Mn |
API Access
Yarrow Bioscience Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=YARW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "YARW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=YARW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();